Investigating the ability of multiparametric MRI to exclude significant prostate cancer prior to transperineal biopsy.

Published version
Repository DOI

Change log
Authors
Serrao, Eva M 
Wadhwa, Karan 
Parashar, Deepak 
Frey, Julia 
Abstract

INTRODUCTION: We characterized false negative prostate magnetic resonance imaging (MRI) reporting by using histology derived from MRI-transrectal ultrasound (TRUS)-guided transperineal (MTTP) fusion biopsies. METHODS: In total, 148 consecutive patients were retrospectively reviewed. Men underwent multiparametric MRI (mpMRI), reported by a consultant/attending radiologist in line with European Society of Urogenital Radiology (ESUR) standards. MTTP biopsy of the lesions was performed according to the Ginsburg recommendations. Cases with an MRI-histology mismatch were identified and underwent a second read by an experienced radiologist. A third review was performed with direct histology comparison to determine a true miss from an MRI-occult cancer. Statistical analysis was performed with McNemar's test. RESULTS: False negative lesions were identified in 29 MRI examinations (19.6%), with a total of 46 lesions. Most false negative lesions (21/46) were located in the anterior sectors of the prostate. The second read led to a significant decrease of false-negative lesions with 7/29 further studies identified as positive on a patient-by-patient basis (24.1% of studies, p = 0.016) and 11/46 lesions (23.9%; p = 0.001). Of these, 30 lesions following the first read and 23 lesions after the second read were considered significant cancer according to the University College London criteria. However, on direct comparison with histology, most lesions were MRI occult. CONCLUSION: We demonstrate that MRI can fail to detect clinically relevant lesions. Improved results were achieved with a second read but despite this, a number of lesions remain MRI-occult. Further advances in imaging are required to reduce false negative results.

Description
Keywords
1112 Oncology and Carcinogenesis, Clinical, Clinical Medicine and Science, Diagnostic Radiology, Cancer, Urologic Diseases, Clinical Research, Prostate Cancer, Cancer
Journal Title
Can Urol Assoc J
Conference Name
Journal ISSN
1911-6470
1920-1214
Volume Title
9
Publisher
Canadian Urological Association Journal
Sponsorship
Prostate Cancer UK (PA14-012)
Cancer Research Uk (None)
National Institute of Health Research Cambridge Biomedical Research Centre, Cancer Research UK, Cancer Research UK and the Engineering and Physical Sciences Research Council Imaging Centre in Cambridge and Manchester, Cambridge Experimental Cancer Medicine Centre